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ABSTRACT
FAM46 proteins, encoded in all known animal
genomes, belong to the nucleotidyltransferase
(NTase) fold superfamily. All four human FAM46
paralogs (FAM46A, FAM46B, FAM46C, FAM46D) are
thought to be involved in several diseases, with
FAM46C reported as a causal driver of multiple
myeloma; however, their exact functions remain un-
known. By using a combination of various bioinfor-
matics analyses (e.g. domain architecture, cellular
localization) and exhaustive literature and database
searches (e.g. expression profiles, protein interac-
tors), we classified FAM46 proteins as active non-
canonical poly(A) polymerases, which modify cy-
tosolic and/or nuclear RNA 3′ ends. These pro-
teins may thus regulate gene expression and prob-
ably play a critical role during cell differentiation. A
detailed analysis of sequence and structure diver-
sity of known NTases possessing PAP/OAS1 SBD
domain, combined with state-of-the-art comparative
modelling, allowed us to identify potential active
site residues responsible for catalysis and substrate
binding. We also explored the role of single point
mutations found in human cancers and propose that
FAM46 genes may be involved in the development of
other major malignancies including lung, colorectal,
hepatocellular, head and neck, urothelial, endome-
trial and renal papillary carcinomas and melanoma.
Identification of these novel enzymes taking part in
RNA metabolism in eukaryotes may guide their fur-
ther functional studies.
INTRODUCTION
Proteins adopting the nucleotidyltransferase (NTase) fold
play crucial roles in various biological processes, such as
RNA stabilization and degradation (e.g. RNApolyadenyla-
tion), RNA editing, DNA repair, intracellular signal trans-
duction, somatic recombination in B cells, regulation of
protein activity, antibiotic resistance and chromatin remod-
elling (1). Almost all known members of this large and
highly diverse superfamily transfer nucleoside monophos-
phate (NMP) from nucleoside triphosphate (NTP) to an ac-
ceptor hydroxyl group belonging to protein, nucleic acid or
small molecule. They are characterized by the presence of a
common /-fold structure composed of a three-stranded,
mixed -sheet flanked by four -helices. This common core
corresponding to the minimal NTase fold is usually deco-
rated by various additional structural elements and addi-
tional domains, depending on the family. Sequence anal-
ysis of distinct members of this superfamily revealed the
following common sequence patterns in NTase fold do-
main: hG[GS], [DE]h[DE]h and h[DE]h (where h indicates
a hydrophobic amino acid) that include conserved active
site residues. Three conserved aspartates/glutamates are in-
volved in the coordination of divalent ions and activation of
the acceptor hydroxyl group of the substrate. Two of them
(from the [DE]h[DE]hmotif) are located on the second core
-strand, while the third carboxylate (from the h[DE]h mo-
tif) is placed on the structurally adjacent third-strand. The
hG[GS] pattern is placed at the beginning of a short, sec-
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ond core -helix and has a crucial role in harbouring the
substrate within the active site (1).
Human members of the NTase fold superfamily are en-
coded by 43 genes (1). Until now, only one group of po-
tentially active human NTases, belonging to the so-called
family-with-sequence-similarity-46 (FAM46), has not been
characterized for its exact biological function. Little is
known about FAM46 proteins apart from their involve-
ment in various diseases. FAM46A, a gene preferentially
expressed in the retina, was reported as a positional can-
didate for human retinal diseases since it maps within the
RP25 locus to chromosome 6p12.1-q14.1 interval where
several retinal dystrophy loci are located (2). It was also sug-
gested that a variable number of tandem repeat polymor-
phisms in FAM46A may be associated with non-small cell
lung cancer (3). Another FAM46 paralog, FAM46B, was
identified to have lower expression in metastatic melanoma
cells (United States Patent US 7615349 B2). FAM46B and
FAM46C have been recently described as potential mark-
ers for refractory lupus nephritis (4) and multiple myeloma
(5–10), respectively. Finally, it was reported that FAM46D
is overexpressed in lung and glioblastoma tumors (11), as
well as together with FAM46C, in the brain of autistic-like
behaving transgenic mice (8).
Functional proteomics studies showed that FAM46A
might havemany potential protein interacting partners (12).
One of them, ZFYVE9, detected in the yeast two-hybrid
system, is involved in the recruitment of unphosphory-
lated SMAD2/SMAD3 to the transforming growth factor-
beta receptor (13). Another member of FAM46 family,
FAM46C, is recognized as a type I interferon stimulated
gene, which enhances the replication of certain viruses (14).
In addition, FAM46C can be an anti-viral factor in acute
infected long-tailed pygmy rice rats by Andes virus (15). It
was also suggested that FAM46C is functionally related in
some way to the regulation of translation (6).
To date, several studies have indicated that proteins be-
longing to FAM46 family might play an essential role in
the cell; however, their exact functions remain unknown. In
our previous work, we performed a comprehensive classi-
fication of the NTase fold proteins and assigned FAM46
proteins to this superfamily as potentially active members
(1). This classification allowed us only to speculate that
like other active NTases, FAM46 members may catalyze
template-independent incorporation of NMP from NTP
either to nucleic acid, protein or small molecule. In this
study we present an in-depth bioinformatics analysis of the
FAM46 family combined with an exhaustive literature and
database searches and propose that the FAM46 proteins
function as non-canonical poly(A) polymerases. Detailed
insight into the sequence and structure diversity of NTases
and their additional N- and C-terminal domains allowed
us to generate a reliable 3D model for one of the family
members (FAM46C) and to confidently identify the poten-
tial active site residues responsible not only for catalysis but
also for substrate binding. In addition, the obtained struc-
tural model for human FAM46C sheds some new light on
the molecular role of mutations found in cancer patients in
the FAM46 genes. Finally, the broad sampling of sequenced
genomes made it possible to track the evolutionary history
of FAM46 proteins back to the origin and hypothesize that
the FAM46 family members are present not only in animals
but also in all four sequenced Dictyosteliidae and two En-
tamoeba (Amebozoa) genomes.
MATERIALS AND METHODS
Sequence searches
Four human FAM46 paralogs (FAM46A, FAM46B,
FAM46C, FAM46D) were used as queries in PSI-BLAST
(16) searches performed against the NCBI non-redundant
(NR) protein sequence database with E-value threshold of
0.001 until profile convergence. Collected sequences were
split into organism-specific sets and clustered with CD-HIT
(17) in order to obtain unique sequences. All FAM46 family
members were aligned using Mafft (18) with some manual
adjustments. The alignment used for phylogeny reconstruc-
tion was additionally trimmed by TrimAl (19) to eliminate
poorly aligned and thus uninformative regions.
Additionally, proteins containing both NTase and C-
terminal four-helical up-and-down bundle fold domains
were collectedwith PSI-BLAST searches performed against
the NCBINR database with E-value threshold of 0.001. Se-
quences (PDB SEQRES) of the following structures pos-
sessing this domain context: pdb|2pbe, pdb|3c18, pdb|3jyy,
pdb|3jz0, pdb|4ebs, pdb|1v4a, pdb|3k7d and pdb|1kan, were
used as queries.
Analysis of gene and protein features
The architecture of the human FAM46 genes was anal-
ysed using the UCSC genome browser (20). Protein lo-
calization was predicted with BaCelLo (21), CELLO (22),
WoLF PSORT (23), Euk-mPLoc 2.0 (24) and MultiLoc
(25). NetNES (26) was used to detect the nuclear export
signal (NES). Protein phosphorylationmotifs were detected
with Eukaryotic LinearMotif (ELM) (27). Gene expression
patterns were analysed using the BioGPS database (28).
Genes with average z-scores higher than 5 (at least in one
probe set) in ‘Barcode on normal tissues’ dataset were con-
sidered as expressed in specific tissue/cell. ‘Barcode on nor-
mal tissues’ dataset provides a survey across diverse normal
human tissues from the U133plus2 Affymetrix microarray
(28). The z-scores in this dataset are generated with the bar-
code function from the R package ‘frma’, which bases on
barcode algorithm (29). The domain architecture was anal-
ysed using Meta-BASIC (30) and SMART (31).
Structural analysis of known NTases
Initially, known NTase fold families and structures were
identified from literature (including our previous classifica-
tion (1)) and various databases of catalogued protein fami-
lies (PFAM (32), COG (33) and KOG (34)) and structures
(PDB (35) and SCOP (36)). This initial set was then used
for a comprehensive, transitive searches for all NTase fold
superfamilymembers using our distant homology detection
method Meta-BASIC (30) and Gene Relational DataBase
(GRDB) system, as described in our previous work (1).
Briefly,Meta-BASIC is a highly sensitivemeta-profile align-
ment method capable of finding very distant similarity be-
tween proteins through a comparison of sequence profiles
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enriched by predicted secondary structures (meta-profiles).
The GRDB system includes precalculated Meta-BASIC
connections between 16 230 PFAM, 4825 KOG and 4873
COG families and 38 498 representative proteins of known
structure (PDB90). Each family and each structure is rep-
resented by its sequence (PDB90) or consensus sequence
(PFAM, COG and KOG), sequence profile (generated with
PSI-BLAST using the NCBI NR70 derivative) and sec-
ondary structure profile (predicted with PSIPRED (37)).
The structural diversity was analysed for all collected
NTase superfamily structures clustered at 90% sequence
identity. Structures were divided into groups based on
their structural similarity using DALI (38). Structure-based
alignments were generated for all considered domains (in-
cluding both the conserved NTase fold and additional N-
andC-terminal domains) after manually curated superposi-
tion of their structures. Secondary structures were assigned
with DSSP (39).
3D model building
Potential templates were identified with Meta-BASIC and
the consensus of fold recognition 3D-Jury approach (40)
using human FAM46 proteins as queries. The sequence-
to-structure alignment between FAM46 family members
and all representative structures possessing both NTase
and PAP/OAS1 SBD domains was built using a consen-
sus alignment approach and 3D assessment (41) based on
Meta-BASIC and 3D-Jury results, PSIPRED secondary
structure predictions and conservation of critical active site
residues and hydrophobic patterns. The 3D model of hu-
manFAM46C protein was built withMODELLER (42) us-
ing Trypanosoma brucei TUTase 4 (pdb|2ikf) (43) as a tem-
plate. Finally, the side chain rotamers were optimized using
SCWRL3 (44). The overall quality of the modelled struc-
ture was checked with ProSA (45). Structure visualization
was carried out with Pymol (http://www.pymol.org).
Analysis of protein interactors
Human members of the NTase fold superfamily were iden-
tified from the UniProt database (46) using our transi-
tive Meta-BASIC search strategy as described above, start-
ing with all collected NTase fold families and structures.
Proteins interacting with human NTase superfamily mem-
bers were identified using the BioGRID database (version
3.4.133) (47). GO annotations (molecular function and bi-
ological process) (48) for detected interactors were taken
from the UniProt database. FAM46 interacting partners
were also identified with manual literature searches.
Analysis of single point mutations in cancers
Missense mutations, found in cancer patients, in FAM46
genes were collected from publications and the following
databases: cBioPortal (49), ICGC (50) and IntOGen (51).
The sequence conservation in FAM46 family was measured
based on Jensen–Shannon divergence (JSD) (52) using cre-
ated FAM46 multiple sequence alignment. The JSD quan-
tifies the similarity between probability distributions with
scores ranging from 0 to 1 (53). A background amino acid
distribution, estimated from a large sequence set, is used
to approximate the distribution of amino acid sites subject
to no evolutionary pressure. Positions in an alignment that
are found to have amino acid distributions very different
from the background distribution are proposed to be func-
tionally important or constrained by evolution. The JSD
score was computed using the score conservation.py pro-
gram (52) with default parameters, e.g. using BLOSUM62
for the background distribution. Positions in FAM46multi-
ple sequence alignmentwithmore than 30%gapswere omit-
ted from JSD computations.
Phylogeny
In order to visualize the relationships between FAM46 fam-
ily members, a phylogenetic analysis was performed with
PhyML3.0 (54) using the LG and JTT models, with an
estimated gamma parameter and proportion of invariable
sites. An approximate branch support was calculated using
the aLTR (55) option implemented in PhyML. Branches
with supports lower than 0.5 were collapsed. The trees were
drawn using iTol (56).
RESULTS AND DISCUSSION
FAM46 family
Firstly, we identified proteins belonging to FAM46 fam-
ily with an exhaustive PSI-BLAST (16) searches performed
against the NCBI NR protein sequence database using
all four human FAM46 paralogs (FAM46A, FAM46B,
FAM46C and FAM46D) as queries. These searches quickly
converged at the third iteration; however, most family mem-
bers can be easily detected even with a simple BLAST
search. This is a feature of compact and very conserved pro-
tein families and graphical clustering of all these sequences
corroborated this observation. As many of them turned out
to be variants or mutants of the same protein (e.g. there
are four FAM46 genes in the human genome and 14 pro-
teins in the NR database) we selected 868 protein sequences
unique for each organism using sequence clustering at dif-
ferent thresholds followed by manual assessment. It should
be noted that some of the detected proteins contain long
deletions within conserved regions, what might be due to
erroneous gene/exon prediction.
Taxonomic distribution
FAM46 proteins are present in the proteomes of all animals.
Supplementary Figure S1 summarizes the taxonomic distri-
bution of all selected 868 FAM46 proteins unique for each
organism. Four FAM46 paralogs can be identified in almost
all sequenced Vertebrata (with high-quality genomes), but
not in Tunicata (Ciona intestinalis and Oikopleura dioica),
Hemichordata (Saccoglossus kowaleskii), Echinodermata
(Strongylocentrotus purpuratus) or Cephalochordata (Bran-
chiostoma floridae), which encode only a single FAM46
protein. Specifically, amphibian, bird, reptile and mam-
mal genomes harbour four distinct FAM46 genes. On the
other hand, fish proteomes contain six to seven FAM46
paralogs due to lineage specific duplications followed by
fast differentiation of the retained paralogs (different in
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each of the four analysed fishes). This evolutionary sce-
nario has been already described in teleost fishes (57). An
asymmetric acceleration of evolutionary rate in one of the
paralogs after the duplication event, manifested by the
high protein sequence divergence and usually leading to
alignment problems in less conserved regions, was also ob-
served in FAM46 paralogs. FAM46 family members are en-
coded in all sequenced animal phyla ranging from Arthro-
poda (Daphnia, Drosophila), Mollusca (Crassostrea gigas),
Nematoda (Caenorhabditis elegans, Brugia malayi, Loa
loa,Trichinella spiralis), Platyhelminthes (Schistosomaman-
soni,Clonorchis sinensis), Cnidaria (Nematostella vectensis),
Placozoa (Trichoplax adherens) and Porifera (Amphime-
don queenslandica). FAM46 genes duplicated and diverged
strongly in some Nematoda lineages leading to a variable
number of paralogs in the analysed genomes. Moreover,
FAM46 proteins are detectable in close metazoan rela-
tives: Choanoflagellida (Salpingoeca sp.,Monosiga brevicol-
lis) and Ichthyosporea (Sphaeroforma arctica). Surprisingly,
proteins belonging to this family can be also found in Ame-
bozoa (four Entamoeba species, Polysphondylium pallidum,
Acytostelium subglobosum and three Dictyostelium species
and Acanthamoeba castellanii) and one Diplomonadida
(Guillardia theta). Choanoflagellida and Ichthyosporea, to-
gether with Metazoa, are a sister group of Fungi and Nu-
cleariids. Noteworthy, FAM46 family members are absent
in fungal and nucleariid genomes sequenced within the
Origins of Multicellularity Project by BROAD. Amebo-
zoa are sometimes grouped with Opisthokonta (Metazoa
and Fungi) into a supertaxon Unikonta characterized by a
single posterior flagellum in flagellated cells. Summarizing,
the presence of FAM46 proteins in proteomes of Metazoa,
Choanoflagellida and Amebozoa suggests its origin in the
ancestor of Unikonta with further divergence into four dis-
tinct conserved representatives in vertebrates.
Phylogeny inference
Phylogenetic relationships were analysed both for a set of
29 representative sequences and for a set of 868 Metazoa,
Choanoflagellida, Diplomonadida and Amebozoa FAM46
proteins. Entamoeba, Giardia and Dictostellids form well-
separated clades with uncertain branching order (Figure
1). They are, however, clearly separated from the Metazoa-
Choanoflagellida clade. Salpingoeca rosetta and M. brevi-
collis form a sister clade to Metazoa. Some of invertebrate
FAM46 proteins display higher variability at sequence level
that can lead to long branches on the phylogenetic tree. The
position of basal lineages within the Metazoa is uncertain
and possible involvement of long branch attraction phe-
nomenon should be taken into account.
The evolutionary history of FAM46 in the vertebrate
genomes is a story of consecutive duplications leading to
four highly similar paralogs. All vertebrate genomes anal-
ysed in this study retained all four FAM46 paralogs. Sur-
prisingly, we detected the presence of FAM46 proteins in
all sequenced Amebozoa genomes.
The divergence time between Choanoflagellida and
Metazoa is estimated ∼600MYA (58,59). As FAM46 genes
are present in Choanoflagellida, Metazoa and Amebozoa
genomes it is possible they were already in the ancestor of
all Unikonta, and therefore also in the ancestor of Ophis-
tokonta. The most likely scenario involves an ancient dele-
tion in the ancestor of Fungi. This evolutionary history
claims FAM46 would be a very ancient gene, what is not re-
flected in its encoded amino acid sequence divergence. Pro-
vided FAM46 have an ancient origin early in the Unikonts,
still the presence of two FAM46 genes in the G. theta
genome requires clarification. Due to cohabitation, it is
plausible that the FAM46 genes in G. theta genome ap-
peared via horizontal gene transfer from Choanoflagellida
to Diplomonadida. However, the low resolution of these
deep branches renders the FAM46 phylogenetic tree (Sup-
plementary Figure S2) uninformative for HGT inference.
There is significant evidence for the transfer occurring in
the opposite direction (60). The mechanism underlying al-
gae to choanoglafellate transfer is supposed to be based on
phagotrophy.We have insufficient data to hypothesize about
the possibility of transfer happening from choanoflagellates
to algae.
Gene structure
The organization, architecture and regulation of human
FAM46 genes and their homologous counterparts in others
organisms seem to contribute to their functional diversifica-
tion. For instance, human FAM46 genes contain 2–3 exons
of which 1–2 are coding (Supplementary Table S1) and they
encode up to five different transcripts. In addition, anti-
sense transcripts have been also detected, e.g. for human
FAM46A (61). Interestingly, we found that the H3K27Ac
pattern in the promoter region and along the coding region
is completely different for each of human FAM46 genes,
what can be related to distinct nucleosome density in these
chromatin regions and different expression patterns (62).
Additionally, the FAM46D gene is in a repeat dense area
as denoted by RepeatMasker, which might be related to the
overall chromosome X repeat density.
Domain architecture
Given the high variability of human FAM46 paralogs
at the gene organization level, the encoded proteins are
surprisingly similar at the sequence level, including the
conservation of various motifs. FAM46 proteins seem to
have a common two-domain architecture composed of
an / region (according to secondary structure predic-
tions) followed by an -helical region. It should be noted
that the FAM46 family is a distant outlier in the NTase
fold superfamily and cannot be identified with standard
sequence comparison methods such as PSI-BLAST. Us-
ing a highly sensitive tool for distant homology detec-
tion, Meta-BASIC (30), we mapped FAM46 proteins, with
the above threshold scores, to several 3D structures in-
cluding the terminal uridylyl transferase 4 (TUTase 4)
from T. brucei (pdb|2ikf) (43), 2′-5′-oligoadenylate synthase
(OAS) from S. scrofa (pdb|1px5) (63), CCA-adding enzyme
from A. fulgidus (pdb|4x4n) (64), cyclic AMP-GMP syn-
thase from V. cholerae (pdb|4u0n) (65), aminoglycoside 6-
adenyltransferase from B. subtilis (pdb|2pbe) and nuclear
factors NF90 and NF45 fromM. musculus (pdb|4at7) (66).
Importantly, FAM46 N-terminal / region has weak but
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Figure 1. Phylogenetic tree of representative FAM46 protein sequences. Maximum likelihood (ML) analysis for selected 29 family members was carried
out using the LG+G model. The approximate likelihood ratio test Shimodaira–Hasegawa-like (SH-like) branch supports above 0.5 are shown. Branches
with support lower than 0.5 were collapsed.
evident sequence similarity to the NTase domain, which
can be confirmed by several fold recognition servers. Meta-
BASIC suggested that the C-terminal -helical part may be
similar either to poly(A) polymerase/2′-5′-oligoadenylate
synthetase 1 substrate binding domain (PAP/OAS1 SBD)
or the domain of four-helical up-and-down bundle fold
(4H), however, it assigned below threshold scores to these
predictions. To figure out what protein fold is adopted by
the FAM46 C-terminal region, we performed a compre-
hensive analysis of the structural diversity of all the avail-
able NTase superfamily structures, both for their conserved
NTase and additional N- and C-terminal domains (Supple-
mentary Figure S3).
While both the PAP/OAS1 SBD and 4H domains pos-
sess four core -helices C-terminal to NTase domain, only
PAP/OAS1 SBD retains the additional (the first core) -
helix located beforeNTase domain.According to secondary
structure predictions, this helix is clearly seen in the FAM46
family members in the conserved region preceding the pre-
dicted NTase domain. In addition to a good mapping of
predicted and observed core secondary structure elements,
FAM46 proteins display also similar conservation of hy-
drophobic motifs and critical residues for NTP binding
(see below) characteristic for the PAP/OAS1 SBD. In our
previous studies we showed that such detailed analysis of
below threshold Meta-BASIC hits usually enables iden-
tification of highly diverged superfamily members which
escape detection even with advanced sequence compari-
son methods. For instance, using this approach we iden-
tified restriction endonuclease-like (67) and RNase H-like
(68) domains in many uncharacterized and poorly anno-
tated protein families. Finally, we found that proteins em-
bracing both the NTase and 4H domains are mainly en-
coded in bacteria and rarely found in archeal genomes, with
single representatives identified in eukaryotic species, in-
cluding fungalMyceliophthora thermophila (gi|367020986),
Tribulus terrestris (gi|367039397) and Rhizophagus irregu-
laris (gi|552919075), and soil-living amoeba Dictyostelium
discoideum (gi|66821023). This is consistent with the bi-
ological functions played by these proteins, as they par-
ticipate in antibiotic resistance (e.g. Staphylococcus aureus
kanamycin nucleotidyltransferase (69), Enterococcus fae-
cium lincosamide antibiotic adenylyltransferase (70), Bacil-
lus subtilis aminoglycoside 6-adenyltransferase) and nitro-
gen assimilation (e.g. Escherichia coli glutamine synthetase
adenyltransferase (71)). In contrast, NTases possessing the
PAP/OAS1 SBD can be widely found in eukaryotes. Al-
together, results of all these analyses strongly suggest that
although displaying little sequence similarity, FAM46 pro-
teins possess PAP/OAS1 SBD consisting of the five right-
handed twisted -helices (with an 1-NTase-2345
topology).
In addition, we found that a few FAM46 proteins pos-
sess additional domains inserted inside the NTase domain
or located at N- or C-termini (Supplementary Figure S4). It
should be noted, however, that the presence of some of these
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additional domains may be a result of potentially incorrect
gene/exon predictions.
PAP/OAS1 SBD in known NTase structures
To identify conserved PAP/OAS1 SBD residues, critical
for binding NTP substrate in an NTase active site, we car-
ried out an exhaustive sequence and structure analysis by
generating the structural alignment of all the representa-
tive structures possessing both the NTase and PAP/OAS1
SBD domains (Figure 2). The PAP/OAS1 SBD specifi-
cally binds a nucleobase of the incoming NTP mainly by
amino acids that provide, either directly or indirectly via
water molecules, Watson–Crick hydrogen bonds. In addi-
tion, a conserved hydrophobic amino acid (e.g. V234 in
poly(A) polymerase Pap1 (72) and Y212 in poly(U) poly-
merase Cid1 (73)), located at the beginning of the third core
-helix of PAP/OAS1 SBD, forms a flat hydrophobic sur-
face for the incoming NTP nucleobase. Proteins containing
the PAP/OAS1 SBD also possess another common residue,
which is responsible for the recognition of a triphosphate
moiety. Conserved lysine/arginine (e.g. K215 in Pap1) lo-
cated in the second core -helix of PAP/OAS1 SBD, to-
gether with a serine from the NTase domain hG[GS] motif,
interact with NTP - and  -phosphate groups.
3D model of human FAM46C
Initially, we generated a sequence-to-structure alignment
of FAM46 family members with all representative pro-
teins of known structure possessing both the NTase and
PAP/OAS1 SBD domains (using their structure-based
alignment described above) (Figure 2). Although these
structures display very little sequence similarity to the
FAM46 proteins, in contrast to our previous work (1)
where we focused in general on the most conserved regions
of NTase fold common to all NTase superfamily mem-
bers, here we were able to propose a reliable and complete
sequence-to-structure alignment for all conserved regions
of both domains. The alignment was guided by secondary
structure predictions and conservation of (i) the NTase
fold active site motifs, (ii) identified critical PAP/OAS1
SBD residues participating in substrate binding and (iii) hy-
drophobic patterns responsible for forming the hydropho-
bic core of the structure.
As a representative of FAM46 family for 3D mod-
elling we selected human FAM46C, which is a potential
biomarker for multiple myeloma. FAM46 proteins are very
similar in sequence, for instance, four human paralogs share
56–75% amino acid identity within the common region en-
compassing both domains. In addition, the length of this
region in these paralogs differs only by 1–2 residues.
The structure of T. brucei TUTase 4 (pdb|2ikf) (43), as
assigned the highest Meta-BASIC score among the pro-
teins possessing bothNTase and PAP/OAS1 SBDdomains,
was used as a template to generate the 3D model of hu-
man FAM46C, based on the manually derived sequence-to-
structure alignment. However, due to the lack of templates
with similar insertion between the last core -strand and
the last core -helix of NTase domain, we were unable to
create a reliable model for 70 amino acids of FAM46C in
this region. Nevertheless, we can speculate that this inser-
tion in FAM46C should fill the space usually occupied by
residues responsible for binding incoming NTP nucleobase
and RNA 5′ end. Figure 3 presents a comparison of the
FAM46C model and existing structures of non-canonical
poly(A) polymerase Trf4p from Saccharomyces cerevisiae,
which is a part of the Trf4p/Air2p/Mtr4p polyadenylation
(TRAMP) complex (74), and the non-catalytic mitochon-
drial dynamic protein MiD51 from M. musculus (75). Im-
portantly, in Trf4p, the region of 53 amino acids between
the fourth and fifth core -helices of the PAP/OAS1 SBD
is crucial for binding the RNA 5′ end and a nucleobase of
the incomingNTP. The corresponding region inFAM46C is
much shorter (only 11 amino acids) and probably is not able
to form the interaction interface for a nucleobase. There-
fore, it is likely that nucleobase binding residues are located
within the 70 amino acids insertion between the last core
-strand and the last core -helix of the FAM46C NTase
domain. In addition, this conserved insertion, composed of
the predicted two -strands and two -helices (with 
order), may also participate in protein–protein interactions
similar to the MiD51 receptor which binds the dynamin-
related protein 1 (Drp1) via a well-conserved loop located
in the NTase domain (75). However, it should be noted
that FAM46C, in contrast to MiD51, seems to be an ac-
tive NTase; therefore, even if the insertion is responsible for
protein–protein interactions, it should also play a role in
substrate recognition.
Active site
Figure 4 shows a comparison of active sites of human
FAM46C (model), poly(A) polymerase Pap1 from S. cere-
visiae (72), poly(U) polymerase Cid1 from Schizosaccha-
romyces pombe (73), CCA-adding enzyme from A. fulgidus
(64), 2’-5’-oligoadenylate synthetase OAS1 from S. scrofa
(76) and the cyclic GMP-AMP synthase (cGAS) from M.
musculus (77). FAM46 proteins probably function as active
NTases because they share all the key motifs in the NTase
domain responsible for catalysis and substrate binding, in-
cluding the [DE]h[DE]h and h[DE]h patterns with three
conserved aspartate/glutamate residues (Asp90, Asp92 and
Glu166) and hG[GS] motif with Gly73 and Ser74 in hu-
man FAM46C. Although we were not able to generate
a complete 3D model of human FAM46C, we were able
to identify additional residues responsible for NTP bind-
ing, which are located in the conserved secondary struc-
ture elements. Comparison of active sites of experimen-
tally solved structures showed that proteins encompassing
both NTase and PAP/OAS1 SBD usually bind a nucle-
obase or a ribose-moiety of incoming NTP by a serine or
a threonine located just before or in the last core -helix of
NTase domain (Figures 2 and 4). Therefore, it is possible
that FAM46C Ser248 may bind, directly or indirectly via a
water molecule, 2′-OH or/and 3′-OH hydroxyl group of a
ribose-base moiety as it is observed for Thr172 in poly(U)
polymerase Cid1 (73) or it can participate in a nucleobase
binding similarly to Thr190 in 2′-5′-oligoadenylate synthase
OAS1 (76). FAM46C shares also all the conserved residues
in PAP/OAS1 SBD responsible for substrate binding. The
FAM46C Leu282 probably interacts with a nucleobase of
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Figure 2. Multiple sequence alignment of human FAM46 proteins, human non-canonical poly(A) polymerases (TUT1-7) and all representative structures
possessing both the NTase and PAP/OAS1 SBD domains. Only conserved regions of the domains are shown. Sequences are labelled with PDB code
or UniProt ID. The numbers of excluded residues are specified in parentheses. Residue conservation is denoted with the following scheme: uncharged,
highlighted in yellow; polar, highlighted in grey; invariant active site residues involved in catalysis, highlighted in black; critical substrate binding residues,
highlighted in red. Locations of observed and predicted secondary structure elements aremarked above the corresponding alignment blocks. Abbreviations:
PAP, poly(A) polymerase; TUTase, terminal uridylyltransferase; CCA, CCA-adding enzyme; OAS, oligoadenylate synthetase; cGAS, cyclic GMP-AMP
synthase; NF45 and NF90, nuclear factors NF45 and NF90; Utp22, U3 small nucleolar RNA-associated protein 22; MiD51 and MiD49, mitochondrial
dynamics proteins MiD51 and MID49; Ss, S. scrofa; Tb, T. brucei; Af, A. fulgidus; Hs,H. sapiens; Mm,M. musculus; Sp, S. pombe; Sc, S. cerevisiae; Vc, V.
cholerae; Bt, B. taurus. Sequence-to-structure alignment for FAM46 proteins can be assigned higher confidence in the NTase domain.
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Figure 3. Comparison of 3Dmodel of human FAM46C and available structures of non-canonical poly(A) polymerase Trf4p (pdb|3nyb) andmitochondrial
dynamics protein MiD51 (pdb|4oaf). Regions in MiD51 responsible for protein–protein interactions and their potential counterpart in FAM46C are
coloured pink. The region between the fourth and fifth core -helices of PAP/OAS1 SBD in FAM46C and Trf4p (critical for nucleobase binding) is shown
in green. The region not modelled in FAM46C (70 amino acids) is denoted by red dots. The conserved active site carboxylates are shown in blue.
Figure 4. Comparison of the active sites of FAM46C, poly(A) polymerase (Pap1, pdb|1fa0), poly(U) polymerase (Cid1, pdb|4fhp), CCA-adding enzyme
(pdb|4x4r), OAS (OAS1, pdb|4rwo) and cyclic GMP-AMP synthase (Mb21d1, pdb|4k97). Only NTase and PAP/OAS1 SBD domains are shown. The
region not modelled in FAM46C (70 amino acids) is denoted by red dots. Conserved amino acids critical for catalysis and substrate binding are shown in
blue.
the incoming NTP like Tyr212 in poly(U) polymerase Cid1
or makes van der Waals contacts with the ribose-base moi-
ety of NTP similar to Val234 in poly(A) polymerase Pap1
(72). Finally, NTP - and  -phosphates most likely inter-
act with the conserved Arg268 in addition to Ser74 from
the hG[GS] motif.
Cellular localization and tissue specificity
According to various servers predicting subcellular local-
ization, the FAM46 proteins seem to be localized in both
the cytoplasm and nucleus. In addition, three human par-
alogs (FAM46B, FAM46C and FAM46D) harbour poten-
tial leucine-rich NES, located at the end of the C-terminal
PAP/OAS1 SBD domain. As a consequence, it is likely that
proteins belonging to the FAM46 family shuttle between
the nucleus and cytoplasm.
We also analysed the gene expression data available in
the BioGPS database (28) and found that each of the hu-
man FAM46 paralogs has a different tissue/cell expres-
sion pattern (Supplementary Table S1). Different expres-
sion patterns probably indicate various biological processes
in which FAM46 proteins participate. According to the
BioGPS database, FAM46A, FAM46B and FAM46C are
potentially expressed in 81, 18 and 66 tissues/cells, respec-
tively, while FAM46D can be found only in sperm (Supple-
mentary Table S1).
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Interacting partners
To get more hints at the biological function of FAM46,
we compared all human NTase superfamily members ac-
cording to GO molecular function and biological pro-
cess of their protein interactors identified in the BioGRID
database (47) (Supplementary Figure S5). We found that
FAM46 binding partners share a common GO functions
and processes mostly with interactors of human NTase fold
proteins from the following four groups (described in Sup-
plementary Table S2): interleukin enhancer-binding fac-
tors, non-canonical poly(A) polymerases (TUT), poly(A)
polymerases (PAP) and zinc finger RNA-binding pro-
teins (ZFR). Similarly to FAM46 family members, pro-
teins belonging to these groups also possess additional
PAP/OAS1 SBD domain. In addition, almost all of them
retain the same biological function––DNA/RNA binding,
including poly(A) RNAbinding and participate in the same
process––transcription.
We also analysed all 61 FAM46 protein interactors iden-
tified in the BioGRID database and the literature in more
details (Supplementary Table S3). We found that each
FAM46 paralog has a different set of interacting protein
partners; therefore, it is likely that each paralog partic-
ipates in a different biological process in the cell. Most
of the interacting partners play important roles in devel-
opment, including cellular proliferation and cell differen-
tiation. We noticed that many FAM46 interactors share
a common molecular functions (e.g. nucleic acids bind-
ing, including binding of the mRNA poly(A) tail) or bio-
logical processes (e.g. protein modification, transcription).
Specifically, 26 FAM46 interacting partners may directly
bind RNA and/or DNA. This group includes: transcrip-
tion (co)factors (RHOXF2, TBX4, NR2F2, SOX5, NRF1,
TRIP6), transcription activators (Znf322, Cxxc5), RNA
stabilization factors (ELAVL1, BCCIP, HDLBP, Pabpc1,
Pabpc4), proteins involved in transcription (POLR1A,
POLR1E, POLR2J), proteins participating in mRNA
translation (EIF4G3, Pabpc1, Pabpc4), proteins taking part
in DNA repair (POLE2, Rad23b, WRAP53) and other
proteins, which play various roles such as DNA heli-
case DDX11, putative RNA exonuclease (44M2.3), mi-
tochondrial translation optimization factor 1 (MTO1),
SUMO-conjugating enzyme UBC9 (UBE2I), 14-3-3 pro-
tein zelta/delta (Ywhaz) involved in signal transduction
(78) and ATXN1, which may participate in RNA export
(79). Similarly to human FAM46A (80), nine protein inter-
actors (ELAVL1, BCCIP, EIF4G3,MTO1,Ywhaz, TRIP6,
UBE2I, Pabpc1, Pabpc4) participate or may participate
in RNA poly(A) tail binding. Another seven FAM46 in-
teracting partners (EGLN2, DAZAP2, KEAP1, DCAF6,
KLHDC2, ZNHIT6, MVP) were shown or suggested to
cooperate with or regulate proteins, which are able to
bind directly to nucleic acids. Specifically, the Egl nine ho-
molog 2 (EGLN2) targets the transcriptional complexHIF-
 subunit for proteasomal degradation (81). KEAP1 tar-
gets transcription factor Nrf2 for ubiquitination and degra-
dation (82). DCAF6 enhances the transcriptional activ-
ity of nuclear receptors NR3C1 and AR (83). The phys-
ical interaction between KLHDC2 and a bZIP transcrip-
tion factor (LZIP) leads to the repression of the LZIP-
dependent transcription (84). DAZAP2 regulates stress or
germ granules–ribonucleoprotein complexes (85,86). MVP
is a part of an evolutionary highly conserved ribonucleo-
protein particles (vaults) (87,88), while ZNHIT6 may be
involved in snoRNP biogenesis (89). Another functional
group of FAM46 interactors contains proteins, which take
part in protein modification (mostly in protein degra-
dation). This group embraces proteases (serine protease
HTRA1, caspase-like protease ESPL1), Kunitz-type pro-
tease inhibitor 1 (SPINT1),Kelch-like ECH-associated pro-
tein 1 (KEAP1) participating in Nrf2 ubiquitination and
degradation (82), EGLN2 targeting HIF- for proteaso-
mal degradation (81), E3 ubiquitin-protein ligases (RNF14,
PARK2), CUL4-associated factor 6 (DCAF6) function-
ing as substrate-recruiting module for CUL4-DDB1 E3
ubiquitin-protein ligase complex (90), SUMO-conjugating
enzyme UBC9 (UBE2I), ubiquitin carboxyl-terminal hy-
drolase 4 (USP4), a regulatory subunit 6A of the 26S pro-
teasome (Psmc3) and BAG6, which is crucial in ubiquitin-
mediated protein degradation of defective or misallocated
polypeptides (91). Among all FAM46 interactors, we were
able to identify two kinases: Polo-like kinase 4 (PLK4) and
non-receptor tyrosine-protein kinase SYK (SYK). PLK
regulates cell cycle progression, mitosis and cytokinesis
(92), while SYK mediates signal transduction and differen-
tiation, particularly in B-cell development (93,94). Another
interacting partner, the FYVE domain-containing protein 9
(ZFYVE9) identified as a SMAD2/3-binding protein, may
also regulate the proliferation of hepatic cells during ze-
brafish embryogenesis (95). The last identified functional
group contains proteins responsible for an intra and ex-
tracellular cell transport, including DYNC1H1––a heavy
chain of cytoplasmic dynein 1 (96,97), RIN3––a small GT-
Pase, which participates in intracellular membrane traffick-
ing (98) andAP2B1, which plays a pivotal role in many vesi-
cle trafficking pathways within the cell (99).
Mutations in cancers
Recent studies have identified numerous somatic mutations
in various cancer patients leading to single point muta-
tions in the human FAM46 proteins (Supplementary Table
S4). For instance, the human FAM46C gene was reported
as a causal driver of multiple myeloma (6). In addition, a
single FAM46C mutation (Y247N) was identified in hem6
mice with hypochromic anemia, which affects terminal
spermiogenesis and terminal stages of erythroid differentia-
tion (100). This study showed that male hem6mice produce
spermwith defects detectable by phase contrast microscopy
and fluorescence microscopy. To analyze the role of these
mutations, we mapped them onto a 3D model of FAM46C
(Figure 5) and found that they can be divided into two
groups. The first group includes mutations that are located
in a highly conserved area of the active site and its close
vicinity, and probably may decrease/increase FAM46 cat-
alytic activity and/or affect substrate binding (e.g. change
the preference for the type of incorporated NTP). This
group embraces the mouse hem6 mutation and the major-
ity of mutations found in multiple myeloma patients as well
as several mutations from other cancers. The average JSD
(52) score for all mutated amino acid positions in multi-
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Figure 5. Missense mutations in FAM46 family members found in cancer patients and hem6 mouse. The positions of the corresponding single point
mutations, mapped onto a 3D model of human FAM46C, are shown as spheres. The spheres are coloured according to JSD score, which refers to the
amino acid conservation in FAM46 family.
ple myeloma (reported in Supplementary Table S4) and for
the mutated residue 247 in hem6 FAM46C is 0.56 and 0.74,
respectively (higher JSD scores correspond to higher se-
quence conservation). In benchmarks JSD approach, which
considers also estimated conservation of sequentially neigh-
bouring sites, performed better than traditional measures
(e.g. Shannon entropy or Sum-of-pairs measure) in identi-
fying functionally important residues (52). In comparison,
the average JSD score for five FAM46 active site residues:
glutamic/aspartic acids, glycine and serine is 0.65. Muta-
tions belonging to the second group are located mostly on
the protein surface (usually with JSD scores below 0.4), in
evolutionary low conserved regions. Those mutations may
affect protein–protein interactions or alternatively might
not play any crucial role in the reported cancers.
In addition, we selected all mutations of highly conserved
residues with a JSD score higher than 0.65 (the average JSD
for five FAM46 active site residues from conserved NTase
motifs). It allowed us to identify mutations found in a num-
ber of malignancies (highlighted in orange in Supplemen-
tary Table S4), which probably have the largest impact on
protein activity and may be connected with diagnosed can-
cers. Consequently, we suggest that, in addition to multiple
myeloma, FAM46 genes may be also involved in pathogen-
esis of various other cancer subtypes including liver hep-
atocellular carcinoma, bladder urothelial carcinoma, head
and neck squamous cell carcinoma, uterine corpus endome-
trial carcinoma, kidney renal papillary cell carcinoma, lung
adenocarcinoma, ductal adenocarcinoma, colorectal ade-
nocarcinoma, primary plasma cell leukemia and skin cuta-
neous melanoma.
Potential function
The results of our sequence and structure analyses suggest
that the FAM46 proteins are active NTases, which have
both the NTase fold and PAP/OAS1 SBD domains. Ac-
tive NTases possessing the PAP/OAS1 SBD are known
to participate in tRNA maturation (CCA-adding en-
zymes), RNA degradation (TUTases, poly(A) polymerase
in TRAMP complex), mRNA maturation (poly(A) poly-
merases) and in a defense response to viruses and bacte-
ria (2′-5′-oligoadenylate synthases and cyclic GMP-AMP
synthases). Although it was shown that both FAM46A and
FAM46C are induced by interferon I and II (14) and that
FAM46C is one of the interferon-stimulated genes (ISGs)
which modify viral (YFV and VEEV) replication during in-
fection, it is unlikely that FAM46 proteins are antiviral en-
zymes like OASes. Unlike replication inhibiting ISGs (such
as OASL, Mab-21 and C6orf150), FAM46C slightly en-
hances the replication of certain viruses (14). FAM46 family
members do not possess also anH(X5)CC(X6)Cmotif (con-
served among vertebrate cGAS members) located between
theNTase and PAP/OAS1 SBDdomains. Thismotif, which
resembles most closely HCCC-type zinc-ribbons found in
TAZdomains, is required for efficient cytosolicDNA recog-
nition (101). Finally, we investigated the possibility that
FAM46 proteins may be novel non-canonical poly(A) poly-
merases participating in RNA 3′ end modification like TU-
Tases or poly(A) polymerases GLD-2 and GLD-3. This hy-
pothesis is consistent with M. Tian studies (100), where
it was shown that mutated FAM46C may modulate the
poly(A) tails of specific transcripts during erythroid differ-
entiation. The author identified a single FAM46C muta-
tion (Y247N) in hem6 mice and showed that it might cause
an accelerated, progressive shrinkage of the poly(A) tail in
four transcripts (alpha-globin, Alas2,Hbb-b1 andFtl1) and
probably does not have any effect on poly(A) tails in two
transcripts (Fth1 and beta-actin). Additionally, a Y247N
mutation led to an increase of expression levels of 152 tran-
scripts, resulted in a decrease of expression levels of 29 tran-
scripts, and did not have any effect on 29 erythroid tran-
scripts (100). It should be noted, however, thatM. Tian used
an indirect approach to analyze the poly(A) tail lengths in
the six aforementioned transcripts. His strategy of indirect
poly(A) tail length assay assumed that the poly(A) tails do
not possess any nucleotides other than adenosines; there-
fore, he was not able to identify the real length of the mod-
ified poly(A) tails if they also contain other nucleotides.
Thus, it is likely that he observed shortening of mRNA
poly(A) tails for specific transcripts if FAM46C is respon-
sible for the addition of adenosines to the RNA 3′ end.
The FAM46C mutation (Y247N) might have weakened the
processivity of FAM46C resulting in poly(A) tails shrink-
age. On the other hand, FAM46C may be a non-canonical
poly(A) polymerase which adds cytidines or uridines to the
RNA 3′ end. In this scenario, FAM46C may participate in
transcript degradation by modifying the poly(A) tails. This
hypothesis is consistent with the fact that up to 152 tran-
scripts increased expression levels in a hem6mutant. In this
case, the observed shortening of the poly(A) tails in four
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transcripts may be a side effect of cell deregulation. In both
scenarios, FAM46 proteins may play a very important role
in mRNA stability as active non-canonical poly(A) poly-
merases rather than some other factors, which prevent early
mRNA degradation by disrupting interactions between ri-
bonuclease docking complex and RNA as suggested by M.
Tian (100). Our functional assignment is also in line with
the facts that mouse FAM46Cmay bind directly or through
a complex toRNACU-richmotifs (100) and FAM46Amay
bind to poly(A) tails (80). According to Chapman et al.,
the expression of FAM46C is highly correlated with the ex-
pression of ribosomal proteins and initiation and elonga-
tion factors involved in protein translation (6). They pro-
posed that FAM46C is functionally related in some way
to the regulation of translation (e.g. as a mRNA stability
factor), however, they did not assign any exact function to
this protein. Recent studies revealed that the poly(A) tail
length impacts gene expression in some processes such as
inflammation, learning and memory (102), and there is a
clear correlation between the poly(A) tail length and trans-
lational efficiency in early development stages in zebrafish
and African clawed frogs (103). Therefore, it is possible that
the correlation observed by Chapman et al. is the effect of
length change of the poly(A) tails.
Both the M. Tian and Chapman et al. studies are con-
sistent with the results of our analysis of FAM46 inter-
actors and interacting partners of all remaining human
NTase fold proteins. We found that FAM46 binding part-
ners share a common GO functions and processes mostly
with interactors of those active NTase fold superfamily
members which belong to non-canonical poly(A) poly-
merases and poly(A) polymerases. We showed that over
half of the 61 identified FAM46 interactors participate in
DNA and/or RNA binding, including nine proteins which
can bind mRNA poly(A) tails. Many of FAM46 interact-
ing partners are involved in transcription or translation,
like transcription (co)factors (RHOXF2, TBX4, NR2F2,
SOX5, NRF1, TRIP6), transcription activators (Znf322,
Cxxc5), RNA stabilization factors (ELAVL1, BCCIP,
HDLBP, Pabpc1, Pabpc4), proteins involved in transcrip-
tion (POLR1A, POLR1E, POLR2J), proteins participat-
ing in mRNA translation (EIF4G3, Pabpc1, Pabpc4), and
proteins taking part in transcription regulation (EGLN2,
KEAP1, DCAF6, KLHDC2) and mitochondrial transla-
tion optimization (MTO1). Finally, some FAM46 protein
interactors regulate or are a part of ribonucleoprotein com-
plexes.
Our domain architecture analysis revealed that proteins
belonging to FAM46 family possess only two domains:
NTase and PAP/OAS1 SBD, with single exceptions of some
additional domains present in a few proteins. Importantly,
we were not able to detect any additional conserved do-
mains such as ferredoxin-like, which plays a critical role
in processivity of canonical poly(A) polymerases or TU-
Tases (Supplementary Figure S3). The ferredoxin-like do-
main provides additional interactions with RNA and may
enhance its binding, allowing the NTase enzyme to add up
to several hundred nucleotides. Therefore, FAM46 proteins
acting as non-canonical poly(A) polymerases probably can
add only a few nucleotides to the RNA 3′ end.
FAM46 family members seem to be localized both in
the cytoplasm and nucleus, like two other human non-
canonical poly(A) polymerases, PAPD4 and PAPD5 (104).
Considering the physiological functions of FAM46 inter-
actors, we can speculate about the biological processes, in
which FAM46 proteins may participate. FAM46A proba-
bly cooperates with a subunit RPB11-a of DNA-directed
RNA polymerase II, eukaryotic translation initiation fac-
tor 4 gamma (eIF4G), high-density lipoprotein-binding
protein (HDLBP, Vigilin), while FAM46C may bind to
polyadenylate-binding proteins (Pabpc1, Pabpc4) and (to-
gether with FAM46A) to ELAV-like protein 1. As a con-
sequence, proteins belonging to FAM46 family can be in-
volved in mRNA (de)stabilization either in the nucleus or
cytoplasm. DNA-directed RNA polymerase II transcribes
all protein-coding genes and synthesizes many functional
non-coding RNAs. The eIF4G3 subunit is a scaffold pro-
tein in eIF4F complex, which participates in the recruit-
ment of eukaryotic mRNAs to the ribosome (105). Pabpc1
and Pabpc4 belong to cytoplasmic poly(A) binding pro-
teins (PABPC), which bind specifically to the poly(A) tail
of mRNA and are required for poly(A) shortening, ribo-
some recruitment and translation initiation (106). Another
protein interactor, Xenopus Vigilin, can selectively protect
in vitro vitellogenin mRNA from cleavage by endonucle-
ase PMR-1 (107), while ELAVL1 is described in the liter-
ature usually as a stabilization factor, which prevents the
degradation of mRNAs possessing short tails (108–110).
FAM46 proteins can be also involved in a ribosome bio-
genesis (like POLR1A, POLR1E interactors (111,112)) or
they can (de)stabilize a nuclear pool of extra-ribosomal
RPL23 and the pre-60S trans-acting factor eIF6 (like BC-
CIP interactor (113)). By interacting with telomerase Cajal
body protein 1 (WRAP53), FAM46 family members may
change 3′ ends of small Cajal body RNAs, which are in-
volved in modifying splicing RNAs (114). Together with
the Box C/D snoRNA protein 1 (ZNHIT6), they may also
participate in snoRNP biogenesis, which is essential for the
processing andmodification of rRNA (89). Finally, FAM46
proteins (together with DAZAP2 and major vault proteins
(MVP)) may modify RNAs which build ribonucleoproteins
complexes like stress granules (85) and vaults composed
of MVP, vault poly(adenosine diphosphate-ribose) poly-
merases (VPARP), telomerase-associated proteins (TEP1)
and small untranslated RNAs (vRNAs) (87,88).
The FAM46 family members seem to be highly regulated
proteins. The process, in which these new non-canonical
poly(A) polymerases participate, is probably determined
by their tissue-specific expression and gene organization.
As reported in the BioGPS database, tissue expression lev-
els are different for each human FAM46 paralog. More-
over, the human FAM46 proteins are likely to be regu-
lated by phosphorylation. Each human paralog has many
phosphorylation patterns detectable with ELM predictor
(27) with high probability scores (data not shown). For in-
stance, FAM46A, FAM46B and FAM46C have two poten-
tial phosphoserine sites (a LIG PLKpattern) recognized by
the Polo-like kinase, which is a known human FAM46C in-
teracting partner.
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CONCLUSION
A comprehensive analysis of various biological information
available in literature and databases combined with numer-
ous sequence and structure analyses (including a state-of-
the-art distant homology detection, fold recognition and
3D modelling) allowed us to propose that FAM46 mem-
bers function as cytoplasmic and/or nuclear non-canonical
poly(A) polymerases. Four human FAM46 paralogs thus
complement the group of already known non-canonical
poly(A) polymerases in humans embracing seven proteins:
RBM21 (U6 TUTase, Star-PAP, TUT6), hGLD2 (PAPD4,
TUT2), hmtPAP (PAPD1, TUT1), POLS (TUT5), PAPD5
(TUT3), ZCCHC6 (TUT7) and ZCCHC11 (TUT4). ZC-
CHC6 and ZCCHC11 mono-uridylate the 3′ end of spe-
cific miRNAs involved in cell differentiation and Home-
obox (Hox) gene control (115). The hmtPAP produces
poly(A) tails in mitochondria (116). The RBM21 catalyzes
the uridylation of U6 snRNA involved in pre-mRNA splic-
ing (117). The hGLD2 generates poly(A) tails of selected
cytoplasmic mRNAs (118). The PAPD5 participates in
the polyadenylation-mediated degradation of aberrant pre-
rRNA and in replication-dependent histone mRNA degra-
dation (119). Unfortunately, we are not able to predict
the exact type of RNA that can be modified by FAM46
proteins. However, taking into account all the identified
FAM46 interacting partners, we can speculate that FAM46
proteins could modify the 3′ end of mRNAs, small Cajal
body RNAs and vRNAs. In addition, they may also partic-
ipate in snoRNP and ribosome biogenesis, and (de)stabilize
a nuclear pool of extra-ribosomal RPL23 and the pre-60S
trans-acting factor eIF6.
The FAM46 family members as well as all the known
non-canonical poly(A) polymerases share the two follow-
ing domains: a PAP/OAS1 SBD with an inserted NTase
domain right after the first core -helix. In this work,
we showed that proteins with such domain architecture,
in addition to highly conserved NTase domain patterns
([DE]h[DE]h, h[DE]h and hG[GS]), possess also three ad-
ditional, conserved amino acids critical for NTP binding.
These residues embrace serine or threonine in the last -
helix of the NTase domain, and lysine/arginine and a hy-
drophobic amino acid located in the second and third
PAP/OAS1 SBD core -helix, respectively. Although the
FAM46 proteins retain serine or cysteine in the last -helix
of the NTase domain, it is possible that the conserved inser-
tion between the last core -strand and -helix in FAM46
NTase domain may substitute the role of the conserved
Ser/Thr at least for some family members, enabling them
to catalyze the modification of selected RNA 3′ ends.
We also performed a systematic search for missense mu-
tations in human FAM46 genes, found in cancer patients.
Collected mutation data from various databases and liter-
ature, combined with sequence/structure analyses suggest
that, in addition to multiple myeloma, FAM46 genes may
be also involved in the development of other major malig-
nancies including lung, colorectal, hepatocellular, head and
neck, urothelial, endometrial and renal papillary carcino-
mas andmelanoma.We identified several single pointmuta-
tions of highly conserved FAM46 amino acids that may af-
fect the enzyme catalytic activity, processivity and substrate
binding (e.g. by changing the preference for the type of in-
corporated NTP). Consequently, these mutations can lead
to deregulation of specific RNAs as an oncogenic mecha-
nism in multiple myeloma and other cancers. This is con-
sistent with previous studies which showed a correlation
between RNA deregulation (e.g. mRNA (120), microRNA
(121,122), long non-coding RNA (123), small non-coding
RNA (124)) and various diseases including cancers.
Summarizing, this work provides functional and struc-
tural annotation for novel and highly important enzymes
involved in RNA metabolism in eukaryotes and thus may
guide functional studies of these previously uncharacterized
proteins. Further experimental investigations should ad-
dress the predicted activity and clarify potential substrates
to provide more insight into the detailed biological roles of
these newly detected non-canonical poly(A) polymerases.
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